Sign in
4

Changes in Ownership

PLIANT THERAPEUTICS, INC. Filed Acc 0001140361-23-002786

President and CEO sold 60,000 shares at an average $33.12 ($1,987,473)

  • President and CEO acquired 45,000 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Coulie Bernard President and CEO 2023-01-23 Option exercise +15,000 $2.08 $31,200 108,812 D: show line 1 in the form
Coulie Bernard President and CEO 2023-01-23 Sale −10,150 $33.71 $342,163 98,662 D: show line 2 in the form
Coulie Bernard President and CEO 2023-01-23 Sale −4,850 $34.93 $169,405 93,812 D: show line 3 in the form
Coulie Bernard President and CEO 2023-01-23 Sale −15,000 $35.00 $525,000 434,317 I: show line 4 in the form
Coulie Bernard President and CEO 2023-01-24 Option exercise +15,000 $2.08 $31,200 108,812 D: show line 5 in the form
Coulie Bernard President and CEO 2023-01-24 Sale −15,000 $30.89 $463,389 93,812 D: show line 6 in the form
Coulie Bernard President and CEO 2023-01-25 Option exercise +15,000 $2.08 $31,200 108,812 D: show line 7 in the form
Coulie Bernard President and CEO 2023-01-25 Sale −13,304 $32.40 $431,058 95,508 D: show line 8 in the form
Coulie Bernard President and CEO 2023-01-25 Sale −1,696 $33.29 $56,459 93,812 D: show line 9 in the form
Open-market sales · 60,000 sh · avg $33.12 · $1,987,473

Table II: Derivative

Insider Date Transaction Shares Price Value Owned after D/I
Coulie Bernard President and CEO 2023-01-23 Option exercise · Stock Option (right to buy) −15,000 232,380 D: show line 10 in the form
Coulie Bernard President and CEO 2023-01-24 Option exercise · Stock Option (right to buy) −15,000 217,380 D: show line 11 in the form
Coulie Bernard President and CEO 2023-01-25 Option exercise · Stock Option (right to buy) −15,000 202,380 D: show line 12 in the form
Loading xslF345X03/form4.xml…